LEP and skin basal cell carcinoma: Additionally, leptin inhibition in obASCs limited the induction of IL-6 expression in BCC by the obASCs, with a 2.3-fold decrease in MCF7 cells, 2.0-fold decrease in ZR75, and 1.5-fold decrease in T47D (P <0.05; Fig. 4; Additional files 3–5).